Xanthohumol and 8-prenylnaringenin have a potent therapeutic effect on diabetic mice, as evidenced by the decreased levels of diabetes-linked biochemical parameters in the liver and kidney. They also decreased the overexpression of galectin-3 (Gal3), which was correlated with oxidative stress in diabetic mice. The gene discussed is LGALS3; the disease is diabetes mellitus.